Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Unit 3 > Liver > Flashcards

Liver Flashcards

1
Q

Hepatitis A transmission

A

oral-fecal; contaminated food or water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hepatitis A symptoms

A

fever, fatigue, nausea, diarrhea, anorexia, jaundice, RUQ pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hepatitis B transmission

A

blood; transfusion, IV drug, sexual contact, hemodialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hepatitis C transmission

A

blood; transfusion, IV drug, sexual contact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Fulminant hepatitis

A

rare and frequently fatal form of acute Hep B in which the pts condition rapidly deteriorates, with hepatic encephalopathy, necrosis of the hepatic parenchyma, coagulopathy, renal failure, and coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Peginterferon

A

used to treat chronic hepatitis B and C; reduces the amount of hepatitis virus in the body and helps immune system fight the infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lamivudine - HBV

A

used to treat hepatitis B; not a cure and does not prevent passing to others; slows the growth of the virus , decreasing the liver damage caused by the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adefovir

A

used to treat chronic viral infection of hepatitis B; slows the growth of the virus; not a cure and does not prevent passing to others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Entecavir

A

used to treat hepatitis B; helps to decrease the amount of hep B in the body; antiviral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Telbivudine

A

used to treat hepatitis B; helps to decrease the amount of hep B in the body; antiviral; not a cure and does not prevent spread of virus to others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ribavirin

A

used in combination with other antivirals; used to treat hep C; reduces the amount of hep C virus in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alcoholic or nutritional cirrhosis (Laennec’s)

A

assoc with chronic ETOH abuse; “when was your last drink”; withdrawal symptoms from 2-12 hrs after last drink (mild anxiety and shakiness to seizures and delirium tremens; thiamine should be administered before glucose as energy source; at risk for Wernicke syndrome; ETOH causes metabolic changes in liver; fat accumulates in liver; potentially reversible if ETOH consumption ceases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Post necrotic cirrhosis

A

results from complication viral hep (esp hep C), and certain other drugs or toxins; liver shrinks because lobules have been destroyed; broad bands of scar tissue form within the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Biliary cirrhosis (cholestatic)

A

assoc with chronic biliary obstruction, autoimmune disease, or infection; retained bile damages and destroys liver cells causing fibrosis of liver; ERCP is done

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Endoscopic Retrograde Cholangiopancreatogram (ERCP)

A

checks the ducts that drain the liver, gallbladder, and pancreas; can treat certain problems found during the test (biopsy an abnormal growth, remove gallstone in the common bile duct, dilate a narrowed bile duct by inserting a stent, measure the pressure inside the bile ducts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cardiac cirrhosis

A

results from long-standing severe right sided heart failure; elevated central venous pressure can cause stasis of blood in veins of liver which leads to fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Causes of cirrhosis - Hep C

A

leading cause; infectious blood borne illness that causes chronic disease; inflammation caused by infection leads to progressive scarring; usually takes decades to develop; ETOH use in combination with Hep C may speed process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Causes of cirrhosis - Hep B

A

causes inflammation and low grade damage over decades; can ultimately lead to cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Causes of cirrhosis - Hep D

A

infects the liver in people who have Hep B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Causes of cirrhosis - ETOH

A

has a direct toxic effect on the hepatocytes; causes liver inflammation; liver becomes enlarged with cellular degeneration and infiltration by fat, leukocytes, and lymphocytes; inflammatory process decreases and destructive phase increases; scar formation is caused by fibroblast infiltration and collagen formation; damage to liver progresses as malnutrition and repeated exposure to ETOH continue; if ETOH is withheld, the fatty infiltration and inflammation is reversible; if ETOH continues, widespread scar tissue formation and fibrosis infiltrate the liver as a result of cellular necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Causes of cirrhosis - biliary

A

occurs as a result of obstruction of the bile duct; pts with PBC typically have a predisposition to the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cirrhosis Pathophysiology

A

end-stage of chronic liver disease; progressive - leads to liver failure; insidious onset with prolonged course; twice as common in men; hepatocytes are destroyed and portal htn develops; liver cells attempt to regenerate; regenerative process is disorganized; functional liver tissue is destroyed; scarring of liver occurs; new fibrous connective tissue distorts liver’s normal structure with impeded blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Liver dysfunction - Neurologic findings

A

asterixis; paresthesias of feet; peripheral nerve degeneration; portal-systemic encephalopathy; reversal of sleep-wake pattern; sensory disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Liver dysfunction - GI findings

A

abdominal pain; anorexia; ascites; clay-colored stools; diarrhea; esophageal varices; fetor hepaticus; gallstones; gastritis; GI bleeding; hemorrhoidal varices; hepatomegaly, hiatal hernia; hypersplenism; malnutrition; nausea; small nodular liver; vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Liver dysfunction - Renal findings

A

hepatorenal syndrome; increased urine bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Liver dysfunction - Endocrine findings

A

increased aldosterone; increased antidiuretic hormone; increased circulating estrogens; increased glucocorticoids; gynecomastia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Liver dysfunction - immune system disturbances

A

increased susceptibility to infection; leukopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Liver dysfunction - cardiovascular findings

A

cardiac dysrhythmias; development of collateral circulation; fatigue; hyperkinetic circulation; peripheral edema; portal hypertension; spider angiomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Liver dysfunction - pulmonary findings

A

dyspnea; hydrothorax; hyperventilation; hypoxemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Liver dysfunction - hematologic findings

A

anemia; DIC; impaired coagulation; splenomegaly; thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Liver dysfunction - dermatologic findings

A

axillary and pubic hair changes; caput medusa; ecchymosis; increased skin pigmentation; jaundice; palmar erythema; pruritus; spider angiomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Liver dysfunction - fluid and electrolyte disturbances

A

ascites; decreased effective blood volume; dilutional hyponatremia or hypernatremia; hypocalcemia; hypokalemia; peripheral edema; water retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Three phases of hepatitis

A

preicteric, icteric, and posticteric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Preicteric phase

A

1st phase of hepatitis; includes n/v, decreased appetite, weight loss, fever, fatigue, HA, joint pain, RUQ abdominal pain, enlarged spleen/liver/lymph nodes, and rash and itching of the skin (urticaria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Icteric phase

A

2nd phase of hepatitis; include preicteric symptoms and jaundice, pruritus, and clay or light colored stools and dark urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Posticteric phase

A

3rd phase of hepatitis; involves cessation of the first two phase symptoms, liver enlargement, and fatigue; complications include need for liver transplant, liver cirrhosis, hepatitis coma, and death; manage hepatitis by following the plan f care; notify provider of signs of bleeding, confusion edema, lethargy, and weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Liver function study - ALT

A

elevated (0-50 norm); enzyme in liver cells; released into bloodstream with injury or disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Liver function study - AST

A

elevated (0-41 norm); enzyme in liver and heart cells; released into bloodstream with injury or disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Liver function study - GGT

A

elevated with cell lysis (8-55 norm); present in all cell membranes; increases when bile ducts are blocked and hepatitis; elevated until function returns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Liver function study - Alkaline phosphatase

A

elevated (44-147 norm); present in liver and bone cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Liver function study - CBC

A

low RBC, Hct, Hgb r/t anemia, RBC destruction bleeding, folic acid, and vitamin deficiencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Liver function study - WBC

A

decreased WBC and platelets; increased blood flow to spleen; cells destroyed faster than needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Liver function study - AFP

A

liver cancer marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Liver function study - lactic dehydrogenase

A

LDH5 specific for liver damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Liver function study - Coagulation

A

prolonged PT (12-13 norm) d/t poor production of prothrombin by liver and decreased Vit K absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Liver function study - INR

A

1.2-2.5 norm; 0.8-1.2 without anticoagulation therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Liver function study - sodium

A

hyponatremia (136-145 norm) d/t hemodilution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Liver function study - potassium

A

hypokalemia (3.5-5 norm) d/t malnutrition and renal loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Liver function study - phosphate

A

hypophosphatemia (2.7-4.5 norm) d/t malnutrition and renal loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Liver function study - magnesium

A

hypomagnesemia (1.5-2.5 norm) d/t malnutrition and renal loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Liver function study - bilirubin

A

total (2-14 norm); direct (0-4); elevated in liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Liver function study - serum albumin

A

low (3.3-5 norm) d/t impaired liver production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Liver function study - ammonia

A

high (0-150 norm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Liver function study - glucose and cholesterol

A

abnormal d/t impaired liver function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Liver function study - abdominal ultrasound

A

liver size, ascites, or nodules

56
Q

Liver function study - esophagascopy

A

look for varicies

57
Q

Needle biopsy

A

most common in past

58
Q

Laparoscopic biopsy

A

used to remove tissue from specific parts of the liver

59
Q

Transvenous biopsy

A

catheter into a vein in the neck and guiding it to the liver; biopsy needle is placed into the catheter and advanced into the liver; used for pts with blood-clotting problems or excess fluid

60
Q

Pre-liver biopsy procedure

A

watch for adequacy of clotting (PT/INR, platelets); type and cross match for blood; hold aspirin, ibuprofen, and anticoagulants; chest x-ray; consent form; NPO 4-8 hrs prior; VS; empty bladder

61
Q

During biopsy procedure

A

supine position; R arm above head; hold breath after expiration when needle inserted; be still during procedure (approx. 20 min); complications - puncture of lung or gallbladder, infection, bleeding, pain

62
Q

Nursing care post liver biopsy

A

pressure to site; pt on right side to maintain pressure for 1-2 hrs; flat for minimum of 3 hrs; VS; check for bleeding; NPO 2 hrs after biopsy; assess for peritonitis, shock, and pneumothorax; R shoulder pain common, usually radiates to shoulder for a few hrs or days; soreness at incision site; avoid aspirin or ibuprofen for pain control for the first week; avoid coughing, straining, lifting for 1-2 wks; rest is priority; diet high cal and protein, low fat; Vit sup B complex and K; avoid ETOH and drugs

63
Q

Portal hypertension

A

results from increased resistance to or obstruction of the flow of blood through the portal vein and its branches; blood seeks alternative venous channels around the high pressure area; blood backs into the spleen; veins in the esophagus, stomach, intestines, abdomen, and rectum become dilated; splenomegaly results from backup of blood into the spleen; enlarged spleen destroys platelets causing thrombocytopenia and increased risk for bleeding (usually the first clinical sign of liver dysfunction); can result in ascites, esophageal varicies, prominent abdominal veins, and hemorrhoids

64
Q

Ascites

A

fluid shift from the vascular system into the abdomen; form of “third spacing”; pt may have hypovolemia and edema at the same time; fluid is plasma filtrate with high concentration of albumin; calcium is attached to albumin decreases so phosphorus increases; potassium is low d/t aldosterone

65
Q

Esophageal varices

A

distention of fragile, thin-walled esophageal veins d/t increased pressure; result of portal hypertension; blood backs up from the liver and enters the esophageal and gastric vessels that carry it into the systemic circulation; bleeding may be either hematemesis or melena

66
Q

Biliary obstruction (coagulation defects)

A

production of bile in the liver is decreased; prevents the absorption of fat soluble vitamins (Vit K); clotting factors are not produced in sufficient quantities and pt is susceptible to bleeding and easy bruising

67
Q

Jaundice

A

caused by: hepatocellular disease - liver cells cannot effectively excrete bilirubin; decreased excretion results in excessive circulating bilirubin levels; or by intrahepatic obstruction - edema, fibrosis, or scarring of the hepatic bile channels and bile ducts; interferes with normal bile and bilirubin excretion; pts with jaundice often report pruritus

68
Q

Portal-systemic encephalopathy (stage 1)

A

Prodomal - subtle manifestations; personality changes; behavior changes; emotional lability; impaired thinking; inability to concentrate; fatigue; drowsiness; slurred or slowed speech; sleep pattern disturbances

69
Q

Portal-systemic encephalopathy (stage 2)

A

Impending - continuing mental changes; mental confusion; disorientation to time, place, or person; asterixis (liver flap)

70
Q

Portal-systemic encephalopathy (stage 3)

A

Stuporous - progressive deterioration; marked mental confusion; stuporous; drowsy but arousable; abnormal electroencephalogram tracing; muscle twitching; hyperreflexia; asterixis

71
Q

Portal-systemic encephalopathy (stage 4)

A

Comatose - unresponsiveness, leading to death in most pts; unarousable, obtunded; usually no response to painful stimulus; no asterixis; positive Babinski’s; muscle rigidity; fetor hepaticus (liver breath: sweet musty odor); seizures

72
Q

Hepatorenal syndrome (HRS)

A

state of progressive oliguric renal failure associated with hepatic failure; results in functional impairment of kidneys with normal anatomic and morphologic features; indicates poor prognosis for pt with hepatic failure; often the cause of death in pts with cirrhosis

73
Q

Spontaneous bacterial peritonitis

A

susceptible pts with very advanced liver disease; bacteria responsible for SBP are from the bowel and reach the ascetic fluid after migrating through the bowel wall and transversing the lymphatics; manifestations may include fever, chills, and abdominal pain and tenderness

74
Q

Treatment of ascites

A

should be focused on dietary restriction of sodium less than 2000 mg daily; use of diuretics (spironolactone and furosemide); fluid restriction for those with serum sodium concentration of less than 120 or symptomatic hyponatremia

75
Q

Treatment of refractory ascites

A

optimization of medical therapy, serial large volume therapeutic paracentesis with the use of IV albumin, TIPS, and liver transplantation; peritoneovenous shunt is palliative measure reserved for pts who are not candidates for other therapies

76
Q

Spontaneous bacterial peritonitis treatment

A

ascritic fluid polymorphonuclear count greater than or equal to 250 cells/mm3 prompts empiric antibiotic treatment with IV cefotaxime for 5 days

77
Q

Treatment for hepatorenal syndrome

A

pts with untreated type 1 have very poor short term survival; should be referred for urgent liver transplantation evaluation; placement of a chest tube is contraindicated in pts with hepatic hydrothorax d/t risk of massive fluid loss and high morbidity and mortality

78
Q

Caput medusae

A

the dilated cutaneous veins around the umbilicus

79
Q

Spider angioma

A

swollen blood vessels found slightly beneath the skin surface; often contains central red spot and reddish extensions which radiate outwards like a spiders web

80
Q

Ascites nursing management

A

assess for resp distress; measure abd girth; high fowler’s; low protein, low sodium diet; k-sparing diuretics; mouth care; monitor for dehydration; perform paracentesis; monitor albumin, daily weight, input/output, fluid and electrolytes; perform fluid wave test

81
Q

Paresentesis for ascites

A

treats resp distress; pt with lose 10-30 g protein; pt in sitting position; empty bladder first

82
Q

Post paresentesis for ascites

A

apply pressure to site; bedrest for 4 hrs; monitor VS hourly x 4 hrs; monitor puncture site for leakage, abd wall hematoma, bowel perf; measure abd girth; monitor Na, Hgb, Hct, input/output, weight post-procedure and daily; admin salt poor albumin as ordered (25 cc for every 2 L ascritic fluid removed; avoids intravascular fluid shift and renal failure after large volume paracentesis)

83
Q

Spironolactone/furosemide

A

diuretic; decreases aldosterone levels, K+ sparing

84
Q

Salt-poor albumin

A

decreases complications of paracentesis such as electrolyte imbalance and increases in serum creatinine levels secondary to large shifts of intravascular volume

85
Q

Neomycin

A

decreases ammonia forming organisms; only recommended when unable to tolerate lactulose

86
Q

Lactulose

A

decreases ammonia forming organisms and inreases acidity of bowel; goal is 2-3 loose stools/day

87
Q

Ferrous sulfate/folic acid

A

treats anemia/vitamin deficiency

88
Q

Propranolol/nadolol

A

beta blocker; prevents bleeding of esophageal varices in conjunction with isosorbide mononitrate; lowers hepatic venous pressure

89
Q

Pantoprazole

A

proton pump inhibitor; decreases irritation of varices

90
Q

Lorazepam/diazepam

A

benzodiazepine; for ETOH withdrawal, sedation, sleep; metabolized in liver; use cautiously

91
Q

Metolazone

A

helps treat edema in CHF; increases excretion of sodium, water, potassium, and hydrogen ions by inhibiting reabsorption of sodium in distal tubules; my be more effective in those with impaired renal function

92
Q

Mannitol

A

inhibits tubular reabsorption of electrolytes by increasing the osmotic pressure of glomerular filtrate; increases urinary output

93
Q

Esophageal varices treatment

A

active bleeding: central line and pulmonary artery pressures; blood transfusions and fresh frozen plasma for clotting factors; somatostatin or vasopressin to constrict gut vessels; nitroglycerine to counter negative affects of vasopressin; airway/trach; prevention of re-bleeding: beta blockers; long-acting nitrates (isosorbide dinatrate, isosorbide mononitrate); soft food, chew well, avoid intra-abdominal pressure; protonix

94
Q

Esophageal varices balloon tube tamponade

A

may be life saving in pts with active variceal bleeding if emergency sclerotherapy or banding is unavailable; main complications are gastric and esophageal ulceration, aspiration pneumonia, and esophageal perforation

95
Q

Sclerotherapy for esophageal varices

A

sclerosant solution is injected into the bleeding varix or the overlying submucosa; complications include fever, dysphagia, chest pain, ulceration, stricture, and perforation

96
Q

Esophageal band ligation for esophageal varices

A

endoscopy loaded with an elastic rubber band is passed through and overtube directly into the varix or varices to be banded; after suctioning the bleeding varix into the tip of the endoscope, the rubber band is slipped over the tissue causing necrosis, ulceration, and sloughing of the varix; complications include superficial ulceration and dysphagia, transient chest discomfort, perforation, aspiration, infection, fever, reduced breathing rate or depth, adverse reaction to sedatives

97
Q

Preop and op esophageal band ligation

A

local anesthetic to numb throat; relaxant medication; pt will lay on left side; VS will be monitored; “bite block” in place; scope into pts mouth down into the esophagus; sucks the enlarged varix into the device chamber and place band(s)

98
Q

Postop esophageal band ligation

A

recovery room; tissue that was banded with slough off; teach to inform provider of persistent pain, bleeding, bloody bowel movement, difficulty swallowing, and n/v

99
Q

Repeated endoscopic treatment for esophageal varices

A

eradicates esophageal varices in most pts; recurrent variceal bleeding is uncommon; because portal htn persists, pt at risk for recurrent varices

100
Q

Long term drug treatment for esophageal varices

A

beta blockers after variceal bleeding; shown to reduce portal blood pressures; lowers risk for further variceal bleeding

101
Q

Prophylactic management for esophageal varices

A

beta blockers have been shown to reduce risk of bleeding

102
Q

Transjugular intrahepatic portosystemic shunt (TIPS)

A

interventional radiologic technique; reduces portal pressure; may be the most effective treatment for pts with diuretic-resistant ascites; under conscious sedation; IVR places a stent percutaneously from the right jugular vein into the hepatic vein, creating connection between the portal and systemic circulations; becoming the standard of care in pts with diuretic-refractory ascites

103
Q

Hepatic encephalopathy

A

alteration in neuro status d/t accumulation of ammonia; precipitating factors: bleeding esophageal varices, narcotics, barbiturates, anesthetics, excessive protein, electrolyte imbalance, hemodynamic alterations, diuretics, severe infection, blood transfusions

104
Q

Hepatic encephalopathy - Onset phase

A

personality changes, disturbances of awareness, forgetfulness, irritability, and confusion

105
Q

Hepatic encephalopathy - Second phase

A

hyperreflexia, asterixis, altered hand writing, violent, abusive behavior

106
Q

Hepatic encephalopathy - Coma

A

positive Babinski’s, hyperactive reflexes obtained with reflex hammer

107
Q

Neomycin - encephalopathy

A

used to kill the bacteria in the gut that produce ammonia; helps prevent impaired brain function

108
Q

Lactulose - encephalopathy

A

acts as a laxative; speeds up the passage of food; decreases the amount of ammonia that is absorbed by the body

109
Q

Protein reduction - encephalopathy

A

ammonia is by-product of protein metabolism

110
Q

S/S liver trauma

A

RUQ pain with abd tenderness; abd distention and rigidity; guarding of abd; increased abd pain exaggerated by deep breathing and referred to the right shoulder

111
Q

S/S hemorrhage and hypovolemic shock

A

hypotension, tachycardia, tachypnea, pallor diaphoresis, cool clammy skin, and confusion or other change in mental state

112
Q

Liver cancer

A

cirrhosis is primary risk factor; Hep C and B are other risk factors; metastatic is more common than primary; may lead to hemorrhage and necrosis; early s/s include hepato/splenomegaly, jaundice, weight loss, ascites, edema, dull abd pain, n/v, anorexia, increased abd girth, pulmonary emboli

113
Q

Liver cancer diagnostics

A

liver scan, CT, MRI, MRA, hepatic angiography, ERCP, laparoscopic liver biopsy, serum alpha fetoprotein

114
Q

Liver cancer treatment

A

surgical intervention, lobectomy, radiofrequency ablation, cryoablation, percutaneous ethanol injection, percutaneous acetic acid injection, chemotherapy, chemoembolization

115
Q

Cryoablation

A

used for unresectable tumors with no s/s of metastasis; liquid nitrogen/argon flows thru cryoprobes into the liver and freezes it

116
Q

Percutaneous ethanol injection (PEI)/percutaneous acetic acid injection (PAI)

A

treat non-metastasized but unresectable liver cancers; ethanol or acetic acid injected into site via ultrasound guided catheter

117
Q

Chemotherapy

A

used when other procedures fail; leucovorin, sorafenib

118
Q

Chemoembolization

A

embolic agent is administered via catheter

119
Q

Liver transplantation

A

option in end-stage liver disease; requires rigorous pre-screening; performed using either deceased or live donor; split liver transplant (one liver for two pts); indications - liver disease r/t chronic viral hepatitis

120
Q

Post op liver transplant complications

A

infection (most can be treated successfully), cancer, and rejection

121
Q

Cyclosporine

A

given to overcome rejection

122
Q

Liver transplant contraindications

A

MELD score 50 or CPP

123
Q

Liver transplant donor evaluated for

A

liver disease, alcohol/drug abuse, cancer, infection, hepatitis, AIDS, blood type, body size

124
Q

Liver transplant rejection

A

about 70% of all liver transplant pts have some degree of organ rejection prior to discharge; anti-rejection medications are given to ward off the immune attack

125
Q

Hyperacute rejection

A

occurs in minutes to hours; caused by anti-donor Ab and complement

126
Q

Accelerated rejection

A

occurs in days; caused by reactivation of T cells

127
Q

Acute rejection

A

occurs in days to weeks; caused by primary activation of T cells

128
Q

Chronic rejection

A

occurs in months to years; unclear as to cause

129
Q

Cyclosporine

A

immunosuppressant; SE - fever, sweating, chills, body aches, flu symptoms, sores in mouth and throat, weight loss, change in mental state, problems with speech or walking, decreased vision, easy bruising or bleeding, pale skin, confusion or weakness, feeling light headed

130
Q

Fluconazole

A

antifungal; SE - allergic reactions, nausea, upper stomach pain, itching, loss of appetite, dark urine, clay colored stools, jaundice, fever, chills, body aches, flu symptoms, severe blistering, peeling, and red skin rash, easy bruising or bleeding, unusual weakness, seizure

131
Q

Mycophenolate

A

immunosuppressant; SE - allergic reactions, signs of infection (notify provider), stomach pain, vomiting, diarrhea, weight loss, ear pain, headache, white patches or sores in mouth or throat, pale skin

132
Q

Nystatin

A

antibiotic; SE - not likely to occur, nausea, stomach upset vomiting, diarhhea

133
Q

Prednisone

A

glucocorticoid; SE - muscle pain/cramps, irregular heartbeat, weakness, swelling hands/ankles/feet, unusual weight gain, signs of infection, vision problems, coffee ground vomit, black/bloody stools, severe stomach/abd pain, mental/mood changes, slow wound healing, thinning skin, bone pain, menstrual period changes, puffy face, seizures, easy bruising/bleeding

134
Q

Prednisolone

A

adrenocortical steroid; SE - cataracts, infections, glaucoma, cushing’s syndrome, muscle wasting, bone loss, HTN, increased appetite, indigestion/heartburn, edema, hyperglycemia, labile moods, sleep disturbances

135
Q

Sirolimus

A

immunosuppressant; SE - increased risk for infections and lymphoma, impaired wound healing, hypercholesterolemia, hypertriglyceridemia, HTN, thrombocytopenia, anemia, arthralgia, acne, rash, increased risk of interstitial pneumonitis and upper resp tract infections, insomnia, tremor

136
Q

Tacrolimus

A

immunosuppressant; SE - nephrotoxicity, hyperkalemia, hypokalemia, hypomagnesemia, HTN, HA, insomnia, weakness, fever, pruritus, n/v, anorexia, abd pain, diarrhea, hyperglycemia, anemia, leukocytosis, abnormal LFT, ascites, peripheral edema, pleural effusion, atelectasis, dyspnea, tremors, paresthesia, back pain

137
Q

Valganciclovir

A

antiviral; serious SE - pale skin, feeling light-headed or SOB, rapid heart rate, trouble concentrating, fever, chills, body aches, flu symptoms, mouth/throat sores, easy bruising, unusual bleeding, petechia, urinating less than usual, drowsiness, confusion, mood changes, increased thirst, loss of appetite, n/v, swelling, weight gain, SOB, seizure; SE - dizziness, loss of balance or coordination, diarrhea, constipation, tremor, cold symptoms

Unit 3 (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions